MGI's Booth at MEDLAB Middle East Triple stacked sliding deck design that's highly compatible with different applicationsBeyond the pipette and gripper functions, MGISP-Smart 8 is extremely user-friendly and flexible with exceptional attention to details. The main workstation's triple stacked sliding deck design is adaptable to different modules, allowing users to flexibly combine modules like building blocks and conveniently replace modules at any time for applications' protocols. With 3...

Dubai, UAE, January 11, 2022 -Global life science innovator MGI Tech Co. Ltd. (MGI) is aiming to boost its market share in the Middle East and Asia through participation at Guangdong Week, a dedicated event taking place at the world exhibition's China Pavilion from January 11-13. The biotech company, which is headquartered in Shenzhen, Guangdong, China, will be demonstrating its sequencing platform DNBSEQ-T7* and its automation system MGISP-NE384 at the event – the technologies that form...

As the pioneer of liquid chip application in agriculture, Molbreeding is committed to improving the detection capacity, reducing test cost and improving the efficiency of molecular breeding of animals and plants. MGI and Molbreeding have reached a strategic cooperation to further promote molecular breeding innovation and industrialization.

On December 20th, 2021, MGI and signed a strategic cooperation agreement with Beijing Anngeen Technology (Anngeen) in Beijing. Under the agreement, MGI and the Anngeen will cooperate on the research and development (R&D) of genetic detection products for cardiovascular diseases based on DNBSEQ-400 gene sequencer* and promote access to individualized diagnosis and treatment programs of cardiovascular diseases in the hospitals to benefit more patients with inherited cardiovascular diseases. Annge...

-- MGI Tech Co., Ltd. ("MGI"), a global life science leader and innovator, is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies. As a responsible global company, and as omicron begins to rapidly spread around the world, MGI's innovative equipment has been used in the detection, monitoring, surveillance, and tracing of the new variant to safeguard the global community in more than 70 countries worldwide to d...

High-throughput next generation sequencing has been successfully utilized in early screening, early diagnosis and real-time monitoring of tumor prognosis in precision medicine. Advancing case analysis and classification, course monitoring and medication guidance clinically. While manual operations in the process of library preparation and target enrichment for NGS can lead to deviations, MGI's automated sample preparation systems automate the labor-intensive and time-consuming procedures in diag...